ELEMENTIS PLC/ADR (OTCMKTS:ELMTY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Zacks.com reports.

According to Zacks, “Elementis plc is a specialty chemicals company. Its business comprises of Specialty Products, Chromium and Surfactants. The company’s product consists of BENTONE(R) organoclays, RHEOLATE(R) rheological additives, DAPRO(R) specialty additives, M-P-A(R) anti-settling agents, NALZIN(R) corrosion and rust inhibitors, THIXATROL(R) rheology additives, NUOSPERSE(R) wetting and dispersing agents, TINT-AYD (R)colorants, SLIP-AYD(R) waxes and slip additives, SERDOX(R) polyglycol ethers, SERDOLAMIDE(R) alkanolamides and SERVOXYL(R) phosphate esters. Elementis plc is based in London, United Kingdom. “

ELMTY stock traded up $0.51 during trading hours on Tuesday, hitting $7.51. 500 shares of the stock were exchanged. The company has a current ratio of 2.56, a quick ratio of 1.43 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $871.16 million, a P/E ratio of 11.04 and a beta of 0.95. The company has a 50-day simple moving average of $7.02 and a two-hundred day simple moving average of $7.96. ELEMENTIS PLC/ADR has a 12 month low of $6.82 and a 12 month high of $13.83.

About ELEMENTIS PLC/ADR

Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.

See Also: Risk Tolerance

Get a free copy of the Zacks research report on ELEMENTIS PLC/ADR (ELMTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ELEMENTIS PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEMENTIS PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.